Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Frits Nelis"'
1
Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
Autor: Niilo Havu, Elly C. Klinkenberg-Knol, P. Snel, John Dent, Frits Nelis, Anders Walan, Jonas Román, David A. Lloyd, Madeline H. Frame, Brent Mitchell, P. J. Prichard
Publikováno v: Gastroenterology. 118:661-669
Background & Aims: The efficacy and safety of long-term acid suppression remains a subject for debate. We report data from patients with refractory reflux esophagitis who were undergoing maintenance therapy with ≥20 mg omeprazole daily for a mean p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b587fe4385f70e33b08665af98f2f90
https://doi.org/10.1016/s0016-5085(00)70135-1
Zobrazit plný text záznamu
2
Omeprazole Versus High-Dose Ranitidine in Mild Gastroesophageal Reflux Disease: Short- and Long-Term Treatment
Autor: Frits Nelis, E Schenk, P. Snel, H. P. M. Festen, Gie Tan
Publikováno v: American Journal of Gastroenterology. 94:931-936
OBJECTIVE Patients with reflux esophagitis suffer from a chronic condition that may cause considerable discomfort because of recurrent symptoms and diminished quality of life. This study was designed to evaluate acute and long-term treatment comparin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fa425a9cd96695cc2d594291cf195588
https://doi.org/10.1111/j.1572-0241.1999.989_l.x
Zobrazit plný text záznamu
3
Screening for coeliac disease in patients fulfilling the Rome II criteria for irritable bowel syndrome in a secondary care hospital in The Netherlands: a prospective observational study
Autor: Egbert-Jan van der Wouden, Juda Vecht, G Frits Nelis
Publikováno v: Gut. 56(3)
Irritable bowel syndrome is the most commonly diagnosed gastrointestinal condition and affects a large proportion of the population in the West.1 Several guidelines suggest that in typical patients with no alarm symptoms or signs, apart from routine
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::839c7c08e1024eebc4365b9ba69c16ae
https://pubmed.ncbi.nlm.nih.gov/17698875
Zobrazit plný text záznamu
4
Decrease in mortality in Lynch syndrome families because of surveillance
Autor: Matti A. Rookus, Fokko M. Nagengast, Frits Nelis, Hans F. A. Vasen, Annemieke Cats, Yvonne M.C. Hendriks, Sybrand Y. de Boer, Jan H. Kleibeuker, Gerrit Griffioen, Andrea E. van der Meulen de Jong
Publikováno v: Gastroenterology, 130, 3, pp. 665-71
Gastroenterology, 130, 665-71
Gastroenterology, 130(3), 665-671. W B SAUNDERS CO-ELSEVIER INC
Item does not contain fulltext BACKGROUND & AIMS: Lynch syndrome family members have a high risk of developing colorectal (CRC), endometrial (EC), and other cancers. A large-scale surveillance program was introduced in The Netherlands in the late 198
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa4cef982cd649880575cb23abe0b439
https://hdl.handle.net/2066/50953
Zobrazit plný text záznamu
8
Long-Term Treatment with Omeprazole for Refractory Reflux Esophagitis: Efficacy and Safety
Autor: Cornelis B.H.W. Lamers, Niilo Havu, H. P. M. Festen, Anton E.G. Lückers, Cornelius P. M. Dekkers, P. Snel, Frits Nelis, Jan B.M.J. Jansen, Stephan G. M. Meuwissen, E. C. Klinkenberg-Knol
Publikováno v: Annals of Internal Medicine. 121:161
Objective: To evaluate the long-term efficacy and safety of omeprazole in patients with gastroesophageal reflux disease resistant to treatment with histamine-2 (H2)-receptor antagonists. Design: Co...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0283d19033096ab19b5cfb5ca00f67ff
https://doi.org/10.7326/0003-4819-121-3-199408010-00001
Zobrazit plný text záznamu
9
Influence of RP 40749 on basal and meal-stimulated serum-gastrin, serum-pepsinogen I, and gastrin-content of the antral mucosa in duodenal ulcer patients
Autor: G. Frits Nelis, Cornelis B.H.W. Lamers, Gerard Pals
Publikováno v: Digestive diseases and sciences. 30(7)
Eighteen patients with active duodenal ulcer were treated with a novel antisecretory drug, RP 40749, either 100 mg or 150 mg as a daily nocturnal dose for 28 days. In these patients we evaluated the clinical course, endoscopic healing rates after 28
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a48b819f8c20d235c2fafa3c09d36840
https://pubmed.ncbi.nlm.nih.gov/4006644
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje